Home / Cabergoline / Czechia
CZ ATC G02CB03 · updated 2 Nov 2026
Cabergoline shortage in Czechia
Is there a Cabergoline shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Cabergoline product is reported short in Czechia, the first since 31 Aug 2026. The company estimate for the return is 23 Nov 2026. Main reason: manufacturing problem.
Also short in Canada, Italy, Norway. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | DOSTINEX 0,5MG 0,5MG TBL NOB 2 II | Pfizer, spol. s r.o., Praha | 31 Aug 2026 | 23 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.